A new study brings us closer to answering why antipsychotics are successful in treating schizophrenia in some patients and not in others.
The perils of job insecurity; depression and cardiac risks; the longest-running mental health study; smart drugs that aren’t so smart; heatstroke in psychiatric patients; an autism puzzler; and psychosis and eating disorders.
New research brings us closer to learning about the associations between psychological states, quality of life, and cardiovascular health.
New data indicate that dementia is largely undiagnosed or unrecognized; exposure to general anesthesia and surgery can lead to a subtle decline in memory and thinking skills in older adults; and sarcopenic obesity in older adults may predict dementia.
This special collection provides new insights on major aspects of depression: psychopharmacology, therapeutic interventions, major depressive episodes, biomarkers, and pseudobulbar affect.
A meta-analysis exploring factors associated with quality of life in first-episode psychosis provides guidance and take-home points for clinicians.
ECT is a highly effective treatment for depression, but a portion of patients fail to respond as hoped. Clinical variables have overall limited utility as a predictor of response. Is inflammation the key?
New research suggests that viruses and metals in the brain may exacerbate Alzheimer disease and deep brain stimulation shows promise in slowing cognitive decline.
Although these medication-assisted treatments have been approved by the FDA and have strong empiric evidence for superior outcomes, it is important to know the good and the bad.
Highlights of 3 new studies investigate how to choose the best therapy for depression as well as the negative influences of polypharmacy and social media.